Targeting the NF-ΚB pathway in prostate cancer: a promising therapeutic approach?

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|3|311-320

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.3, 2016-03, pp. : 311-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ameliorated Chemotherapeutic Potential of Diverse Dose Flouropyrimidine Therapy By Etodolac via NF-ΚB Pathway, PPAR-γ Expression and COX-II Inhibition in DMH Induced Colon Cancer Rats

By  

Clinical Cancer Drugs, Vol. 3, Iss. 2, 2016-10 ,pp. : 109-120

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer

By Zhang Yiming   Huang Hai   Zhou Huimin   Du Tao   Zeng Lexiang   Cao Yi   Chen Jieqing   Lai Yiming   Li Jin   Wang Ganping   Guo Zhenghui  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3208-3218

Blackwell Publishing

Access to resources Recommend Favorite

Targeting NF-κB for colorectal cancer

By Sakamoto Kei   Maeda Shin  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 593-601

Informa Healthcare

Access to resources Recommend Favorite

MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 259-271

Bentham Science Publishers

Access to resources Recommend Favorite

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite